| Detected | Trial | Change |
|---|---|---|
| 2026-08-08 | NCT06804590 A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With… |
Trial completed |
| 2026-08-08 | NCT06804590 A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With… |
date change Completion moved earlier: 2026-07-30 -> 2026-06-30 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06592326 | 9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or… | Urothelial Carcinoma | Recruiting |
| NCT06692166 | A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With… | Cervical Cancer | Recruiting |
| NCT06196736 | A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated… | Advanced Urothelial Carcinoma | Recruiting |
| NCT07556848 | A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally… | Locally Advanced or Metastatic Triple-negative Breast Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT06492005 | A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic… | Triple-Negative Breast Cancer | Recruiting |
| NCT06823427 | 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial… | Urothelial Carcinoma | Recruiting |
| NCT07292714 | A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Pulmonary Disease COPD | Recruiting |
| NCT07314723 | 9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer | Urothelial Carcinoma | Recruiting |
| NCT07576608 | A Phase II Study of 9MW3811 in Patients With Pathological Scar | Scar | Recruiting |
| Phase 1/2 | |||
| NCT06079112 | 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic… | Advanced Urothelial Carcinoma | Recruiting |
| NCT07265622 | First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors | Solid Tumors | Recruiting |
| NCT07466160 | A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors | Solid Tumor | Recruiting |
| NCT07216560 | First-in-human Study of 7MW4911 in GI Cancer | GI Cancers | Recruiting |
| NCT05990452 | Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Active, Not Recruiting |
| NCT06926998 | 9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors | Gynecological Malignancies | Not Yet Recruiting |
| NCT06947226 | A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in… | Solid Tumors | Not Yet Recruiting |
| NCT06175351 | Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and… | Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | Active, Not Recruiting |
| Phase 1 | |||
| NCT05773937 | A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors | Advanced Malignant Solid Tumors | Recruiting |
| NCT06772766 | A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent… | Beta-Thalassemia | Recruiting |
| NCT06752746 | A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity… | Polycythemia Vera | Recruiting |
| NCT06908928 | A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated… | Triple Negative Breast Cancer | Recruiting |